Back to Stock Analysis

BioSyent$RX

1 research article

BioSyent ($RX) has 1 independent research article on RhinoInvestory, written by 1 analyst.

Analysts Covering BioSyent

Planet MicroCap

Research Articles

BioSyent (TSX-V: RX): Specialty Pharmaceutical Company Focused on Commercializing Assets in Canada

By Planet MicroCap • 2023-09-19T15:45:38.306Z